Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

UiPath Appoints Raghu Malpani as Chief Product and Technology Officer

UiPath said Chief Technology Officer Raghu Malpani is taking on an expanded role as chief product and technology officer, effective March 25, 2026.

Malpani joined UiPath in May 2024 and will now lead both the product and engineering teams. He continues to report to CEO and Executive Chairman Daniel Dines.

The company said the move is designed to bring product roadmaps and customer transformation goals closer together as it pushes further into AI, automation and orchestration. Dines said Malpani’s expanded remit reflects his “builder’s mindset” and his work on the core platform around orchestration, automation and AI.

Malpani spent nearly two years as CTO before the promotion. Before UiPath, he held leadership roles at Microsoft across Microsoft 365 application and data platform, Microsoft Exchange Core, Copilot Semantic Index Platform, Microsoft Graph and several Azure cloud offerings. He also led Meta’s global Decisions Platform team.

In his new role, Malpani said the company is focused on building a platform where agents, robots and people work together, combining intelligence with governance and control. The market has reacted to these announcements by moving the company's shares -3.04% to a price of $14.34. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS